(3R)-3-AMINO-4-(2,5-DIFLUOROPHENYL)-1-(3-(TRIFLUOROMETHYL)-5,6-DIHYDRO(1,2,4)TRIAZOLO(4,3-A)PYRAZIN-7(8H)-YL)BUTAN-1-ONE
UNII 3BND42HHK2
Substance Identification & Data
This profile provides standardized clinical and technical data for (3r)-3-amino-4-(2,5-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8h)-yl)butan-1-one, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3BND42HHK2.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 486460-31-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C16H16F5N5O ABTMQWQGGARRSK-LLVKDONJSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (3r)-3-amino-4-(2,5-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8h)-yl)butan-1-one. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.